tiprankstipranks
Rapid Dose Therapeutics to Issue Shares for Quarterly Interest on Debt
Company Announcements

Rapid Dose Therapeutics to Issue Shares for Quarterly Interest on Debt

Story Highlights

Stay Ahead of the Market:

Rapid Dose Therapeutics Corp ( (TSE:DOSE) ) has issued an announcement.

Rapid Dose Therapeutics Corp. announced its intention to issue common shares to satisfy the accrued interest on its secured convertible notes as part of its private placement financing. This move, consistent with previous quarters, involves issuing 430,930 common shares at a price of $0.22 per share to cover $94,806.23 of accrued interest, reflecting the company’s commitment to structured financial strategies and stakeholder engagement.

More about Rapid Dose Therapeutics Corp

Rapid Dose Therapeutics Corp. is a Canadian biotechnology company focused on innovative drug delivery solutions. Its flagship product, QuickStrip™, is an orally dissolvable film designed for the rapid delivery of active ingredients such as nutraceuticals, pharmaceuticals, and vaccines directly into the bloodstream.

YTD Price Performance: 2.27%

Average Trading Volume: 53,197

Technical Sentiment Consensus Rating: Sell

Current Market Cap: C$28.04M

For a thorough assessment of DOSE stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskRapid Dose Therapeutics Issues Shares to Settle Debt
TipRanks Canadian Auto-Generated NewsdeskRapid Dose Therapeutics Unveils Lidocaine Oral Strip Innovation
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App